Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_assertion evidence source_evidence_literature NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_assertion SIO_000772 20959405 NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_assertion wasDerivedFrom gad-20130706 NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_assertion wasGeneratedBy ECO_0000203 NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
- gad-20130706 importedOn "2013-07-06" NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.